51 results
Categories
Human Remove Human filter
Patient safety
Yes Remove Yes filter
-
List item
News: Synchron Research Service: suspension of medicines over flawed studies
CHMP, Last updated: 20/05/2022 -
List item
News: COVID-19: latest safety data provide reassurance about use of mRNA vaccines during pregnancy
CHMP, PRAC, Last updated: 18/01/2022 -
List item
News: CHMP endorses review finding no link between viral vector in Zynteglo and blood cancer
CAT, CHMP, Last updated: 23/07/2021 -
List item
News: Vaxzevria: further advice on blood clots and low blood platelets
CHMP, Last updated: 21/05/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: benefits and risks in context
CHMP, Last updated: 23/04/2021 -
List item
News: AstraZeneca’s COVID-19 vaccine: EMA to provide further context on risk of very rare blood clots with low blood platelets
CHMP, Last updated: 14/04/2021 -
List item
News: Nitrosamines: EMA aligns recommendations for sartans with those for other medicines
CHMP, Last updated: 13/11/2020 -
List item
News: Ulipristal acetate for uterine fibroids: EMA recommends restricting use
CHMP, Last updated: 13/11/2020 -
List item
News: Authorised uses of cancer medicine Yondelis unchanged following review of new data
CHMP, Last updated: 24/07/2020 -
List item
Press release: Risks of Picato for actinic keratosis outweigh benefits
CHMP, Last updated: 30/04/2020 -
List item
Press release: EMA recommendations on DPD testing prior to treatment with fluorouracil, capecitabine, tegafur and flucytosine
CHMP, Last updated: 30/04/2020 -
List item
Press release: Suspension of ranitidine medicines in the EU
CHMP, Last updated: 30/04/2020 -
List item
Press release: Recommendations to restrict use of fosfomycin antibiotics
CHMP, Last updated: 27/03/2020 -
List item
Press release: No change is needed in use of direct oral anticoagulants following EMA-funded study
CHMP, Last updated: 27/03/2020 -
List item
Press release: Benefits of medicines containing combination of methocarbamol and paracetamol continue to outweigh risks
CHMP, Last updated: 27/03/2020 -
List item
Press release: EMA confirms Xeljanz to be used with caution in patients at high risk of blood clots
CHMP, Last updated: 15/11/2019 -
List item
Press release: Measures to minimise risk of serious side effects of multiple sclerosis medicine Lemtrada
CHMP, Last updated: 15/11/2019 -
List item
Press release: New measures to avoid potentially fatal dosing errors with methotrexate for inflammatory diseases
CHMP, Last updated: 23/08/2019 -
List item
Press release: Increased risk of blood clots in lungs and death with higher dose of Xeljanz (tofacitinib) for rheumatoid arthritis
CHMP, Last updated: 20/03/2019 -
List item
Press release: Sartan medicines: companies to review manufacturing processes to avoid presence of nitrosamine impurities
CHMP, Last updated: 01/02/2019 -
List item
Press release: No new patients should start treatment with Lartruvo after study shows cancer medicine does not prolong life
CHMP, Last updated: 23/01/2019 -
List item
Press release: EMA recommends aligning doses of metamizole medicines and their use during pregnancy and breastfeeding
CHMP, Last updated: 14/12/2018 -
List item
Press release: Omega-3 fatty acid medicines no longer considered effective in preventing heart disease
CHMP, Last updated: 14/12/2018 -
List item
Press release: Disabling and potentially permanent side effects lead to suspension or restrictions of quinolone and fluoroquinolone antibiotics
CHMP, Last updated: 16/11/2018 -
List item
Press release: EMA restricts use of prostate cancer medicine Xofigo
CHMP, Last updated: 27/07/2018